NCT04483791 - DynamX Bioadaptor Hong Kong Registry | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions

Coronary Artery Disease

Interventions

COMBINATION_PRODUCT

DynamX Novolimus Eluting Coronary Bioadaptor System

up to two de novo native coronary artery lesions measuring between 2.25 and 3.5 mm in diameter and\<=34 mm in length receiving the DynamX Novolimus Eluting Coronary Bioadaptor System

Trial Locations (4)

Unknown

Kwong Wah Hospital, Hong Kong

Queen Elizabeth Hospital, Hong Kong

Queen Mary Hospital, Hong Kong

Chinese University of Hong Kong / Prince of Wales Hospital, Hong Kong